ELTX

Elicio Therapeutics, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-12

Figures on this page computed 2026-11-08 12:56 UTC

Last close

1.56USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-12

  • n/aP/E

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2025
    Accession
    0001601485-26-000027
    Reported in
    USD
    • computed
    • 10-K for 2025, filed 2026-03-12

    The filing itself

  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2025
    Accession
    0001601485-26-000027
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-12
    • 10-K for 2025, filed 2026-03-12
    • 10-K for 2025, filed 2026-03-12
    • 10-Q for 2025, filed 2026-08-13
    • 10-K for 2025, filed 2026-03-12
    • 10-Q for 2025, filed 2026-08-13

    The filing itself

  • n/aNet margin

    We do not hold this figure for this company, so there is nothing to place.

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001601485-26-000027
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-12
    • 10-K for 2025, filed 2026-03-12

    The filing itself

  • n/aFCF margin

    We do not hold this figure for this company, so there is nothing to place.

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001601485-26-000027
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-12
    • 10-K for 2025, filed 2026-03-12

    The filing itself

  • 8.87Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2025
    Accession
    0001601485-26-000027
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-12
    • 10-Q for 2025, filed 2026-08-13

    The filing itself

  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed

Ten years as a story

lens 9 of 9
2023-11-17 to 2026-11-041.56
Its closing price: 5.91 on 2023-11-17 to 1.56 on 2026-11-04, down 74%.

Every filing we hold, oldest first

6
  1. 2022-03-30Annual report for 202010-K
  2. 2022-03-30Annual report for 202110-K
  3. 2023-03-17Annual report for 202210-K
  4. 2024-03-29Annual report for 202310-K
  5. 2025-03-31Annual report for 202410-K
  6. 2026-03-12Annual report for 202510-K

6 filings over the years we hold, each pinned to the day it landed.

6 filings over the years we hold, each pinned to the day it landed.

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.